Viewing Study NCT02622334


Ignite Creation Date: 2025-12-25 @ 2:39 AM
Ignite Modification Date: 2026-03-02 @ 8:17 AM
Study NCT ID: NCT02622334
Status: COMPLETED
Last Update Posted: 2018-03-14
First Post: 2015-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT).
Sponsor: Hoffmann-La Roche
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glaucoma View
Keywords: